
BioCryst Pharmaceuticals (BCRX) Earnings Dates & Reports
BioCryst Pharmaceuticals (BCRX) Most Recent Earnings
Report DateAug 4, 2025
Period EndingQ2 2025
Est. EPS$0.03
Actual EPS$0.15
EarningsBeat
BioCryst Pharmaceuticals (BCRX) Earnings
View the latest BioCryst Pharmaceuticals (BCRX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in BioCryst Pharmaceuticals (BCRX)
Order type
Buy in
Order amount
Est. shares
0 shares
BioCryst Pharmaceuticals (BCRX) Earnings per Share (EPS) History
Signup for full accessBrowse free
BioCryst Pharmaceuticals (BCRX) Latest Earnings
The value each BCRX share was expected to gain vs. the value each share gained.
BioCryst Pharmaceuticals (BCRX) reported its most recent earnings on Aug 4, 2025 for Q2 2025, posting earnings per share (EPS) of $0.15. This exceeded analysts' expectations of $0.03 by 400.00%, marking a Beat.
For comparison, BioCryst Pharmaceuticals reported EPS of -$0.06 in the same quarter last year.
The company is expected to announce its next earnings report on 11/03/2025, with analysts projecting an EPS of -$0.05.
BioCryst Pharmaceuticals (BCRX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 3, 2025 | $0.03 | Next earnings call Nov. 3, 2025 | ||
Q2 2025Aug 4, 2025 | $0.03 | $0.15 | +400.00% | |
Q1 2025May 5, 2025 | -$0.05 | Next earnings call Nov. 3, 2025 | ||
Q4 2024Feb 24, 2025 | -$0.06 | -$0.13 | +116.67% | |
Q3 2024Nov 4, 2024 | -$0.06 | -$0.07 | +16.67% | |
BioCryst Pharmaceuticals (BCRX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the BioCryst Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 4, 2025 | — | — | — |
May 5, 2025 | — | — | — |
Feb 24, 2025 | — | — | — |
Nov 4, 2024 | — | — | — |
BioCryst Pharmaceuticals (BCRX) Earnings FAQs
BioCryst Pharmaceuticals (BCRX) last reported earnings on Aug 4, 2025 for Q2 2025, posting an EPS of $0.15, which Beat the estimate of $0.03 by 400.00%.
For Q2 2025, BioCryst Pharmaceuticals (BCRX) reported an EPS of $0.15, exceeding analysts' estimate of $0.03 by 400.00%.
For Q2 2025, BioCryst Pharmaceuticals (BCRX) Beat expectations with an actual EPS of $0.15 vs. an estimated EPS of $0.03.
Following the last earnings report on Aug 4, 2025, BioCryst Pharmaceuticals (BCRX)'s stock price moved — from — to —.
The next BioCryst Pharmaceuticals (BCRX) earnings call is scheduled for Nov. 3, 2025, where executives will discuss financial results and outlook.